Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia
Clinical trial NCT00265551 · COMPLETED
Trial details
- NCT number
- NCT00265551
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.